KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Revenue (2016 - 2026)

Cme has reported Revenue over the past 18 years, most recently at $1.9 billion for Q1 2026.

  • Quarterly Revenue rose 14.48% to $1.9 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.8 billion through Mar 2026, up 7.54% year-over-year, with the annual reading at $6.5 billion for FY2025, 6.37% up from the prior year.
  • Revenue was $1.9 billion for Q1 2026 at Cme, up from $1.6 billion in the prior quarter.
  • Over five years, Revenue peaked at $1.9 billion in Q1 2026 and troughed at $1.2 billion in Q4 2022.
  • The 5-year median for Revenue is $1.5 billion (2024), against an average of $1.5 billion.
  • Biggest five-year swings in Revenue: rose 19.17% in 2023 and later fell 2.95% in 2025.
  • Tracing CME's Revenue over 5 years: stood at $1.2 billion in 2022, then rose by 19.17% to $1.4 billion in 2023, then grew by 5.98% to $1.5 billion in 2024, then rose by 8.09% to $1.6 billion in 2025, then grew by 14.04% to $1.9 billion in 2026.
  • According to Business Quant data, Revenue over the past three periods came in at $1.9 billion, $1.6 billion, and $1.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.